During an event hosted by MEP Romana Jerkovic, Vice-President of the Public Health Committee at the European Parliament, a report from the European Society for Medical Oncology was presented, showing that clinical research is concentrated in countries with greater economic resources rather than in those with high incidence and mortality, while surprising discrepancies show that some Western European economies lag and regions in northern and southern Europe lead in terms of access to studies. The report indicates that Romania remains underrepresented in the European oncology clinical trial landscape, with a relatively low number of trials compared to Western European countries, reflecting gaps in research infrastructure, limited capacity of clinical trial sites, and administrative and regulatory challenges affecting study initiation and conduct.